If you liked this article you might like

Shire Beats Full-Year Earnings Estimates, Sees Robust 2017 Growth
Biotech Buoyed by Deal Talk
5 Toxic Stocks to Avoid
Why Shire, Great Plains, GE Are Waving Red Flags